# Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

> **NCT07478471** · — · NOT_YET_RECRUITING · sponsor: **Emergent BioSolutions** · enrollment: 10 (estimated)

## Conditions studied

- Infections, Bacterial

## Interventions

- **BIOLOGICAL:** Collection of samples

## Key facts

- **NCT ID:** NCT07478471
- **Lead sponsor:** Emergent BioSolutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-05
- **Primary completion:** 2030-05
- **Final completion:** 2030-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478471, "Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT07478471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*